Remote Oncology MSL: Lead Scientific Engagement & Trials

Placements24; Durban; Hybrid; ZAR 800,000 - 1,200,000; Full time

Benefits offered by this job

Highly competitive salary

Executive-level health, dental, and

Generous travel and expense reimburse

Fully remote position with autonomy

Professional development support

Job summary

Placements24 is seeking an experienced Medical Science Liaison in Oncology to join a fully remote team. You will engage with KOLs, HCPs, and research institutions to foster scientific exchange and support clinical development and appropriate use of the oncology portfolio.

The role requires extensive travel (up to 70%), clear scientific communication, and contributions to regional medical strategies while aligning with global objectives.

Qualifications

• MD/PhD/PharmD advanced clinical degree
• Minimum 4 years as Medical Science Liaison, oncology preferred
• Deep oncology science and clinical knowledge
• Proven ability to communicate complex scientific information to diverse audiences
• Strong understanding of clinical research processes and pharma regulations
• Willingness to travel up to 70% for field-based engagements

Responsibilities

• Establish and maintain relationships with KOLs and HCPs in oncology.
• Deliver scientific and clinical information to respond to unsolicited requests.
• Identify and support potential clinical trial sites and investigators for company-sponsored studies.
• Present complex data at medical conferences, advisory boards, and investigator meetings.
• Gather insights from KOLs/HCPs on clinical practice, needs, and competitive landscape.
• Contribute to regional medical strategies and align tactical plans with global objectives.

Job description

Placements24 is seeking an experienced Medical Science Liaison in Oncology to join a fully remote team. You will engage with KOLs, HCPs, and research institutions to foster scientific exchange and support clinical development and appropriate use of the oncology portfolio.

The role requires extensive travel (up to 70%), clear scientific communication, and contributions to regional medical strategies while aligning with global objectives.